Algernon Pharmaceuticals Strikes Deal to Advance Ifenprodil in Chronic Cough Treatment
Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to announce a significant agreement regarding the company’s drug, Ifenprodil with U.S. Based Seyltx. Originally discovered in Japan and...
Read More